Insiders · Profile

Almon Einat Brill

SVP, Product Development at Protalix BioTherapeutics. Filing since 12 May 2008. CIK 0001385116

Company
Date
Role
Action
Shares
Amount
Of holding
2 May 2012
SVP, Product Development
Sold, plan not stated
166,848
$1.19M
100%
6 Oct 2010
VP, Product Development
Sold, plan not stated
15,000
$139.35K
100%
5 Oct 2010
VP, Product Development
Sold, plan not stated
20,000
$181.60K
100%
4 Oct 2010
VP, Product Development
Sold, plan not stated
35,000
$315.70K
100%
7 Sep 2010
VP, Product Development
Sold, plan not stated
22,500
$183.60K
100%
3 Sep 2010
VP, Product Development
Sold, plan not stated
27,500
$220.00K
100%
19 Oct 2009
VP, Product Development
Sold, plan not stated
38,320
$361.36K
100%
16 Oct 2009
VP, Product Development
Sold, plan not stated
23,680
$222.36K
100%
15 Oct 2009
VP, Product Development
Sold, plan not stated
28,000
$262.92K
100%
7 Jul 2009
VP, Product Development
Sold, plan not stated
11,000
$54.45K
100%
6 Jul 2009
VP, Product Development
Sold, plan not stated
44,000
$225.72K
100%
18 May 2009
VP, Product Development
Sold, plan not stated
40,000
$160.00K
100%
12 May 2008
VP, Product Development
Bought
41,427
$113.92K
opened
13 decisions on file.